Sotera Health Statistics
Share Statistics
Sotera Health has 283.24M shares outstanding. The number of shares has increased by 0.21% in one year.
Shares Outstanding | 283.24M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | 0.05% |
Owned by Institutions (%) | n/a |
Shares Floating | 152.75M |
Failed to Deliver (FTD) Shares | 5.44K |
FTD / Avg. Volume | 0.45% |
Short Selling Information
The latest short interest is 8.98M, so 3.17% of the outstanding shares have been sold short.
Short Interest | 8.98M |
Short % of Shares Out | 3.17% |
Short % of Float | 5.88% |
Short Ratio (days to cover) | 10.58 |
Valuation Ratios
The PE ratio is 92.16 and the forward PE ratio is 19.1. Sotera Health's PEG ratio is 0.38.
PE Ratio | 92.16 |
Forward PE | 19.1 |
PS Ratio | 4.51 |
Forward PS | 3.2 |
PB Ratio | 10.67 |
P/FCF Ratio | -13.05 |
PEG Ratio | 0.38 |
Enterprise Valuation
Sotera Health has an Enterprise Value (EV) of 6.76B.
EV / Earnings | 131.59 |
EV / Sales | 6.44 |
EV / EBITDA | 16.09 |
EV / EBIT | 24.43 |
EV / FCF | -18.64 |
Financial Position
The company has a current ratio of 2.42, with a Debt / Equity ratio of 5.06.
Current Ratio | 2.42 |
Quick Ratio | 2.19 |
Debt / Equity | 5.06 |
Total Debt / Capitalization | 83.49 |
Cash Flow / Debt | -0.07 |
Interest Coverage | 1.94 |
Financial Efficiency
Return on equity (ROE) is 0.12% and return on capital (ROIC) is 4.84%.
Return on Equity (ROE) | 0.12% |
Return on Assets (ROA) | 0.02% |
Return on Capital (ROIC) | 4.84% |
Revenue Per Employee | 349.76K |
Profits Per Employee | 17.13K |
Employee Count | 3.00K |
Asset Turnover | 0.34 |
Inventory Turnover | 9.08 |
Taxes
Income Tax | 54.65M |
Effective Tax Rate | 0.52 |
Stock Price Statistics
The stock price has increased by -16.88% in the last 52 weeks. The beta is 2.08, so Sotera Health's price volatility has been higher than the market average.
Beta | 2.08 |
52-Week Price Change | -16.88% |
50-Day Moving Average | 14.71 |
200-Day Moving Average | 13.51 |
Relative Strength Index (RSI) | 43.8 |
Average Volume (20 Days) | 1.22M |
Income Statement
In the last 12 months, Sotera Health had revenue of $1.05B and earned $51.38M in profits. Earnings per share was $0.18.
Revenue | 1.05B |
Gross Profit | 577.16M |
Operating Income | 276.69M |
Net Income | 51.38M |
EBITDA | 420.20M |
EBIT | 276.69M |
Earnings Per Share (EPS) | 0.18 |
Balance Sheet
The company has $296.41M in cash and $2.33B in debt, giving a net cash position of -$2.03B.
Cash & Cash Equivalents | 296.41M |
Total Debt | 2.33B |
Net Cash | -2.03B |
Retained Earnings | -654.44M |
Total Assets | 3.15B |
Working Capital | 368.08M |
Cash Flow
In the last 12 months, operating cash flow was -$147.73M and capital expenditures -$214.97M, giving a free cash flow of -$362.71M.
Operating Cash Flow | -147.73M |
Capital Expenditures | -214.97M |
Free Cash Flow | -362.71M |
FCF Per Share | -1.29 |
Margins
Gross margin is 55%, with operating and profit margins of 26.37% and 4.9%.
Gross Margin | 55% |
Operating Margin | 26.37% |
Pretax Margin | 10.1% |
Profit Margin | 4.9% |
EBITDA Margin | 40.05% |
EBIT Margin | 26.37% |
FCF Margin | -34.57% |
Dividends & Yields
SHC does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | 1.37% |
FCF Yield | -9.74% |
Analyst Forecast
The average price target for SHC is $17, which is 29.3% higher than the current price. The consensus rating is "Buy".
Price Target | $17 |
Price Target Difference | 29.3% |
Analyst Consensus | Buy |
Analyst Count | 6 |
Scores
Altman Z-Score | 1.28 |
Piotroski F-Score | 7 |